Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.
about
Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Optimizing the Use of Antibacterial Agents in the Neonatal Period.Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants.Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes.Guidance on the risk assessment of substances present in food intended for infants below 16 weeks of agePrediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates.
P2860
Q38696468-46AF2DE6-D85D-44D8-AB18-E8D02BE4D965Q38922653-7ACE463D-B3C2-4CF1-845D-13F8B6F9D605Q39167922-620BF107-DCF2-4832-9EA3-F968CAC35D2FQ46523360-058F1C64-F010-4761-B968-E37E1AFC0EBAQ47159532-B38CC779-4F01-4A1E-AEE8-F80DFABD3837Q50468318-29DD86FC-187D-4B6F-9095-D1F3AF158FFAQ55454780-00976CA3-DD23-44CD-93EC-1F9D3EBB9DDF
P2860
Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.
@en
type
label
Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.
@en
prefLabel
Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.
@en
P2093
P2860
P356
P1476
Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future
@en
P2093
Alison L Jones
Jennifer J Schneider
Kate O'Hara
P2860
P304
P356
10.1111/BCP.12741
P407
P577
2015-10-26T00:00:00Z